201 related articles for article (PubMed ID: 10471061)
1. Human CYP2B6: expression, inducibility and catalytic activities.
Gervot L; Rochat B; Gautier JC; Bohnenstengel F; Kroemer H; de Berardinis V; Martin H; Beaune P; de Waziers I
Pharmacogenetics; 1999 Jun; 9(3):295-306. PubMed ID: 10471061
[TBL] [Abstract][Full Text] [Related]
2. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
[TBL] [Abstract][Full Text] [Related]
3. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
Roy P; Yu LJ; Crespi CL; Waxman DJ
Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.
Martin H; Sarsat JP; de Waziers I; Housset C; Balladur P; Beaune P; Albaladejo V; Lerche-Langrand C
Pharm Res; 2003 Apr; 20(4):557-68. PubMed ID: 12739762
[TBL] [Abstract][Full Text] [Related]
5. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
[TBL] [Abstract][Full Text] [Related]
6. [Cloning of the human cytochrome p450 2B6 gene in Escherichia coli cells].
Kolomeĭchuk SN; Pokrovskaia MV; Borisova AA; Zhgun AA; Solodar' LI; Sokolov NN; Shvets VI; Gervaziev IuV; El'darov MA; Archakov AI
Vopr Med Khim; 2001; 47(6):609-19. PubMed ID: 11925752
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of the expression in liver and catalytic activity of CYP2B6.
Ekins S; Vandenbranden M; Ring BJ; Gillespie JS; Yang TJ; Gelboin HV; Wrighton SA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1253-9. PubMed ID: 9732386
[TBL] [Abstract][Full Text] [Related]
8. Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.
Hanna IH; Reed JR; Guengerich FP; Hollenberg PF
Arch Biochem Biophys; 2000 Apr; 376(1):206-16. PubMed ID: 10729207
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
Chang TK; Weber GF; Crespi CL; Waxman DJ
Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.
Liu Z; Li L; Wu H; Hu J; Ma J; Zhang QY; Ding X
Drug Metab Dispos; 2015 Feb; 43(2):208-16. PubMed ID: 25409894
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
12. Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice.
Li-Masters T; Morgan ET
Drug Metab Dispos; 2001 Mar; 29(3):252-7. PubMed ID: 11181491
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
Sarikaya D; Bilgen C; Kamataki T; Topcu Z
Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
Yanagihara Y; Kariya S; Ohtani M; Uchino K; Aoyama T; Yamamura Y; Iga T
Drug Metab Dispos; 2001 Jun; 29(6):887-90. PubMed ID: 11353758
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
Doehmer J; Weiss G; McGregor GP; Appel K
Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
[TBL] [Abstract][Full Text] [Related]
16. Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes.
Woodcroft KJ; Novak RF
J Pharmacol Exp Ther; 1999 May; 289(2):1121-7. PubMed ID: 10215695
[TBL] [Abstract][Full Text] [Related]
17. Role of human CYP2B6 in S-mephobarbital N-demethylation.
Kobayashi K; Abe S; Nakajima M; Shimada N; Tani M; Chiba K; Yamamoto T
Drug Metab Dispos; 1999 Dec; 27(12):1429-33. PubMed ID: 10570024
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of BDE-47 to potentially toxic metabolites is predominantly mediated by human CYP2B6.
Feo ML; Gross MS; McGarrigle BP; Eljarrat E; Barceló D; Aga DS; Olson JR
Environ Health Perspect; 2013 Apr; 121(4):440-6. PubMed ID: 23249762
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory monoclonal antibody to human cytochrome P450 2B6.
Yang TJ; Krausz KW; Shou M; Yang SK; Buters JT; Gonzalez FJ; Gelboin HV
Biochem Pharmacol; 1998 May; 55(10):1633-40. PubMed ID: 9633999
[TBL] [Abstract][Full Text] [Related]
20. Stable expression of human cytochrome CYP2B6 and CYP1A1 in Chinese hamster CHL cells: their use in micronucleus assays.
Wu J; Dong H; Cai Z; Yu Y
Chin Med Sci J; 1997 Sep; 12(3):148-55. PubMed ID: 11360624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
